| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.618 | 0.005 | 0.618 | GABA C receptor rho-3 antagonist | 0.508 0.024 CID_21806134 0.531 0.018 CID_19432906 0.386 0.068 CID_154699581 0.366 0.077 CID_154699503 | ||
| 0.557 | 0.018 | 0.557 | 5 Hydroxytryptamine release inhibitor | 0.485 0.037 CID_21806134 0.551 0.019 CID_19432906 0.363 0.105 CID_154699581 0.355 0.111 CID_154699503 | ||
| 0.555 | 0.019 | 0.555 | 5 Hydroxytryptamine release stimulant | 0.32 0.064 CID_21806134 0.426 0.041 CID_19432906 0.353 0.056 CID_154699581 0.287 0.074 CID_154699503 | ||
| 0.451 | 0.003 | 0.451 | Ferrochelatase inhibitor | 0.29 0.008 CID_21806134 0.414 0.004 CID_19432906 0.262 0.012 CID_154699581 0.272 0.01 CID_154699503 | ||
| 0.452 | 0.01 | 0.452 | Cyclic AMP phosphodiesterase inhibitor | 0.337 0.029 CID_21806134 0.309 0.038 CID_19432906 0.288 0.047 CID_154699581 0.297 0.043 CID_154699503 | ||
| 0.47 | 0.041 | 0.47 | Histamine release inhibitor | 0.406 0.073 CID_21806134 0.464 0.043 CID_19432906 0.296 0.125 CID_154699581 0.258 0.149 CID_154699503 | ||
| 0.455 | 0.039 | 0.559 | Aldehyde oxidase inhibitor | 0.559 0.025 CID_21806134 0.506 0.032 CID_19432906 0.173 0.121 CID_154699581 0.147 0.142 CID_154699503 | CID_21806134 | |
| 0.426 | 0.022 | 0.443 | Superoxide dismutase inhibitor | 0.443 0.02 CID_21806134 0.361 0.034 CID_19432906 0.178 0.144 CID_154699581 0.189 0.13 CID_154699503 | CID_21806134 | |
| 0.465 | 0.075 | 0.549 | Caspase 9 stimulant | 0.35 0.146 CID_21806134 0.415 0.102 CID_19432906 0.549 0.045 CID_154699581 0.455 0.08 CID_154699503 | CID_154699581 | |
| 0.377 | 0.034 | 0.377 | Calcium channel activator | 0.336 0.059 CID_21806134 0.364 0.041 CID_19432906 0.246 0.152 CID_154699581 0.266 0.128 CID_154699503 | ||
| 0.335 | 0.011 | 0.335 | Phosphodiesterase inhibitor | 0.205 0.033 CID_21806134 | ||
| 0.328 | 0.012 | 0.344 | Neurotrophic factor enhancer | 0.344 0.01 CID_21806134 0.292 0.02 CID_19432906 0.234 0.048 CID_154699581 0.232 0.05 CID_154699503 | CID_21806134 | |
| 0.346 | 0.03 | 0.389 | Interleukin agonist | 0.389 0.02 CID_21806134 0.327 0.036 CID_19432906 0.218 0.104 CID_154699581 0.194 0.126 CID_154699503 | CID_21806134 | |
| 0.34 | 0.03 | 0.497 | Peroxidase inhibitor | 0.382 0.023 CID_21806134 0.497 0.01 CID_19432906 0.114 0.106 CID_154699503 | CID_19432906 | |
| 0.338 | 0.029 | 0.338 | 5 Hydroxytryptamine uptake stimulant | 0.219 0.118 CID_21806134 0.274 0.061 CID_19432906 0.25 0.08 CID_154699581 0.259 0.072 CID_154699503 | ||
| 0.327 | 0.022 | 0.327 | Tyrosine 3 hydroxylase inhibitor | 0.287 0.04 CID_21806134 0.281 0.044 CID_19432906 0.214 0.113 CID_154699581 0.211 0.117 CID_154699503 | ||
| 0.301 | 0.005 | 0.301 | GABA C receptor rho-2 antagonist | 0.244 0.013 CID_21806134 0.231 0.016 CID_19432906 0.159 0.062 CID_154699581 0.143 0.083 CID_154699503 | ||
| 0.398 | 0.102 | 0.398 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.313 0.195 CID_21806134 0.336 0.167 CID_19432906 | ||
| 0.337 | 0.051 | 0.337 | Aryl hydrocarbon receptor agonist | 0.18 0.114 CID_21806134 0.256 0.076 CID_19432906 | ||
| 0.291 | 0.005 | 0.291 | Porphobilinogen synthase inhibitor | 0.254 0.007 CID_21806134 0.247 0.008 CID_19432906 0.07 0.056 CID_154699581 0.101 0.035 CID_154699503 | ||
| 0.29 | 0.03 | 0.29 | Non-steroidal antiinflammatory agent | 0.282 0.032 CID_21806134 0.24 0.047 CID_19432906 0.151 0.113 CID_154699503 | ||
| 0.323 | 0.071 | 0.327 | Vasodilator, coronary | 0.313 0.077 CID_21806134 0.247 0.137 CID_19432906 0.327 0.068 CID_154699581 0.279 0.106 CID_154699503 | CID_154699581 | |
| 0.313 | 0.065 | 0.39 | Lipoxygenase inhibitor | 0.295 0.073 CID_21806134 0.39 0.04 CID_19432906 0.183 0.159 CID_154699581 0.193 0.148 CID_154699503 | CID_19432906 | |
| 0.324 | 0.077 | 0.408 | Cholesterol antagonist | 0.408 0.048 CID_21806134 0.337 0.07 CID_19432906 0.258 0.12 CID_154699581 0.279 0.105 CID_154699503 | CID_21806134 | |
| 0.257 | 0.026 | 0.257 | MAP kinase kinase 3 inhibitor | 0.224 0.066 CID_21806134 0.236 0.047 CID_19432906 | ||
| 0.226 | 0.007 | 0.242 | Creatine kinase inhibitor | 0.242 0.006 CID_21806134 0.187 0.013 CID_19432906 0.129 0.035 CID_154699581 0.161 0.02 CID_154699503 | CID_21806134 | |
| 0.221 | 0.009 | 0.221 | GABA C receptor antagonist | 0.173 0.02 CID_21806134 0.19 0.015 CID_19432906 0.125 0.047 CID_154699581 0.114 0.059 CID_154699503 | ||
| 0.216 | 0.006 | 0.216 | GABA C receptor rho-1 antagonist | 0.173 0.014 CID_21806134 0.183 0.011 CID_19432906 0.104 0.057 CID_154699581 0.092 0.074 CID_154699503 | ||
| 0.255 | 0.047 | 0.255 | RNA-directed DNA polymerase inhibitor | 0.211 0.085 CID_21806134 0.189 0.116 CID_19432906 0.188 0.119 CID_154699581 0.197 0.103 CID_154699503 | ||
| 0.335 | 0.129 | 0.528 | Calcium channel L-type activator | 0.38 0.095 CID_21806134 0.528 0.018 CID_19432906 | CID_19432906 | |
| 0.288 | 0.082 | 0.389 | Interleukin 2 agonist | 0.389 0.03 CID_21806134 0.284 0.086 CID_19432906 0.221 0.155 CID_154699581 0.237 0.134 CID_154699503 | CID_21806134 | |
| 0.25 | 0.05 | 0.25 | Anesthetic general | 0.177 0.089 CID_21806134 0.206 0.071 CID_19432906 | ||
| 0.273 | 0.077 | 0.273 | Insulysin inhibitor | 0.256 0.091 CID_21806134 0.187 0.179 CID_19432906 | ||
| 0.21 | 0.016 | 0.21 | Nav1.6 sodium channel blocker | 0.161 0.042 CID_21806134 0.123 0.092 CID_19432906 | ||
| 0.213 | 0.022 | 0.213 | Arachidonic acid antagonist | 0.206 0.028 CID_21806134 0.198 0.035 CID_19432906 0.204 0.029 CID_154699581 0.211 0.023 CID_154699503 | ||
| 0.195 | 0.004 | 0.195 | Leukotriene D4 antagonist | 0.103 0.005 CID_21806134 0.043 0.011 CID_19432906 0.046 0.011 CID_154699581 0.045 0.011 CID_154699503 | ||
| 0.245 | 0.061 | 0.245 | Neuropeptide Y2 antagonist | 0.182 0.154 CID_19432906 | ||
| 0.197 | 0.013 | 0.213 | Photosensitizer | 0.213 0.01 CID_21806134 0.187 0.016 CID_19432906 0.122 0.054 CID_154699581 0.167 0.022 CID_154699503 | CID_21806134 | |
| 0.254 | 0.075 | 0.263 | Gastrin inhibitor | 0.263 0.065 CID_21806134 0.224 0.113 CID_19432906 | CID_21806134 | |
| 0.208 | 0.032 | 0.208 | Nav1.2 sodium channel blocker | 0.201 0.034 CID_21806134 0.11 0.095 CID_19432906 0.163 0.05 CID_154699581 0.193 0.037 CID_154699503 | ||
| 0.226 | 0.05 | 0.226 | Insulin sensitizer | 0.216 0.058 CID_21806134 0.223 0.053 CID_19432906 0.181 0.094 CID_154699581 0.19 0.085 CID_154699503 | ||
| 0.179 | 0.005 | 0.179 | Phosphodiesterase XI inhibitor | 0.105 0.028 CID_21806134 0.087 0.046 CID_154699581 0.084 0.052 CID_154699503 | ||
| 0.179 | 0.005 | 0.179 | Phosphodiesterase 11A inhibitor | 0.105 0.028 CID_21806134 0.087 0.046 CID_154699581 0.084 0.052 CID_154699503 | ||
| 0.184 | 0.013 | 0.184 | Nitric-oxide synthase inhibitor | 0.119 0.039 CID_21806134 0.096 0.067 CID_19432906 | ||
| 0.183 | 0.014 | 0.3 | Alcohol dehydrogenase inhibitor | 0.3 0.005 CID_21806134 0.101 0.051 CID_19432906 | CID_21806134 | |
| 0.175 | 0.007 | 0.198 | Leukotriene antagonist | 0.198 0.006 CID_21806134 0.14 0.012 CID_19432906 0.08 0.032 CID_154699581 0.079 0.033 CID_154699503 | CID_21806134 | |
| 0.21 | 0.047 | 0.21 | 5 Hydroxytryptamine 3E antagonist | 0.185 0.093 CID_21806134 | ||
| 0.171 | 0.008 | 0.171 | Phosphodiesterase 5A inhibitor | 0.084 0.036 CID_21806134 | ||
| 0.168 | 0.009 | 0.172 | Histamine N-methyltransferase inhibitor | 0.172 0.009 CID_21806134 0.098 0.047 CID_19432906 0.091 0.054 CID_154699581 | CID_21806134 | |
| 0.192 | 0.033 | 0.25 | Toll-Like receptor antagonist | 0.25 0.015 CID_21806134 | CID_21806134 | |
| 0.179 | 0.022 | 0.179 | 5 Hydroxytryptamine 3A agonist | 0.104 0.071 CID_21806134 | ||
| 0.164 | 0.009 | 0.164 | Phosphodiesterase V inhibitor | 0.083 0.039 CID_21806134 | ||
| 0.24 | 0.086 | 0.24 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.167 | 0.014 | 0.167 | Phosphodiesterase I inhibitor | 0.099 0.045 CID_21806134 | ||
| 0.199 | 0.05 | 0.229 | Succinate dehydrogenase inhibitor | 0.229 0.031 CID_21806134 0.211 0.041 CID_19432906 0.152 0.109 CID_154699581 0.161 0.094 CID_154699503 | CID_21806134 | |
| 0.276 | 0.131 | 0.276 | Calpain 2 inhibitor | |||
| 0.149 | 0.005 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.01 CID_21806134 0.128 0.011 CID_19432906 0.086 0.061 CID_154699581 0.083 0.067 CID_154699503 | ||
| 0.148 | 0.006 | 0.148 | Phosphodiesterase X inhibitor | 0.07 0.016 CID_21806134 | ||
| 0.148 | 0.006 | 0.148 | Phosphodiesterase 10A inhibitor | 0.07 0.016 CID_21806134 | ||
| 0.163 | 0.021 | 0.189 | Gastric antisecretory | 0.189 0.014 CID_21806134 0.174 0.018 CID_19432906 0.091 0.077 CID_154699581 | CID_21806134 | |
| 0.155 | 0.015 | 0.155 | CYP2A6 inhibitor | |||
| 0.149 | 0.009 | 0.149 | Leukotriene synthesis inhibitor | 0.115 0.019 CID_21806134 0.138 0.011 CID_19432906 0.105 0.023 CID_154699581 0.105 0.023 CID_154699503 | ||
| 0.171 | 0.033 | 0.171 | Sphingosine 1-phosphate receptor 5 antagonist | 0.168 0.035 CID_21806134 0.13 0.099 CID_19432906 | ||
| 0.152 | 0.015 | 0.222 | Macrophage migration inhibitory factor inhibitor | 0.222 0.006 CID_21806134 0.076 0.056 CID_19432906 | CID_21806134 | |
| 0.139 | 0.003 | 0.139 | Cytokine production stimulant | 0.118 0.004 CID_21806134 0.062 0.011 CID_19432906 0.066 0.009 CID_154699581 0.057 0.016 CID_154699503 | ||
| 0.159 | 0.025 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_21806134 0.17 0.013 CID_19432906 0.151 0.041 CID_154699581 0.152 0.039 CID_154699503 | CID_19432906 | |
| 0.149 | 0.016 | 0.149 | Inducible nitric-oxide synthase inhibitor | 0.08 0.063 CID_21806134 0.081 0.06 CID_19432906 | ||
| 0.153 | 0.021 | 0.153 | Prolactin inhibitor | 0.084 0.075 CID_21806134 0.092 0.064 CID_19432906 0.083 0.076 CID_154699581 | ||
| 0.142 | 0.01 | 0.142 | Nicotinic alpha4beta2 receptor antagonist | 0.13 0.013 CID_21806134 0.074 0.057 CID_154699581 0.076 0.054 CID_154699503 | ||
| 0.18 | 0.05 | 0.18 | Neurotensin receptor agonist | 0.158 0.083 CID_21806134 0.147 0.109 CID_19432906 | ||
| 0.138 | 0.008 | 0.138 | Transforming growth factor antagonist | 0.102 0.02 CID_21806134 | ||
| 0.242 | 0.113 | 0.242 | Ca(v)3.3 blocker | |||
| 0.217 | 0.088 | 0.259 | Antiamyloidogenic | 0.259 0.067 CID_21806134 0.233 0.079 CID_154699581 0.241 0.075 CID_154699503 | CID_21806134 | |
| 0.171 | 0.045 | 0.171 | CF transmembrane conductance regulator agonist | 0.135 0.107 CID_21806134 0.147 0.082 CID_19432906 | ||
| 0.166 | 0.041 | 0.166 | Glutamate receptor antagonist | 0.115 0.079 CID_21806134 0.115 0.08 CID_19432906 | ||
| 0.161 | 0.036 | 0.161 | Pregnane X receptor agonist | 0.159 0.038 CID_21806134 0.159 0.039 CID_19432906 0.143 0.067 CID_154699581 0.127 0.109 CID_154699503 | ||
| 0.25 | 0.127 | 0.339 | Vasodilator, peripheral | 0.197 0.18 CID_21806134 0.339 0.079 CID_19432906 | CID_19432906 | |
| 0.146 | 0.024 | 0.169 | Folate antagonist | 0.169 0.016 CID_21806134 | CID_21806134 | |
| 0.177 | 0.055 | 0.198 | Phospholipase A2 inhibitor | 0.198 0.044 CID_21806134 0.124 0.11 CID_19432906 | CID_21806134 | |
| 0.126 | 0.005 | 0.168 | Aconitate hydratase inhibitor | 0.168 0.004 CID_21806134 0.155 0.004 CID_19432906 0.058 0.028 CID_154699581 0.063 0.023 CID_154699503 | CID_21806134 | |
| 0.249 | 0.128 | 0.281 | Transcription factor NF kappa B inhibitor | 0.252 0.126 CID_21806134 0.281 0.106 CID_19432906 0.223 0.148 CID_154699581 0.233 0.14 CID_154699503 | CID_19432906 | |
| 0.132 | 0.012 | 0.132 | Glycine receptor antagonist | 0.089 0.044 CID_21806134 0.114 0.022 CID_19432906 0.105 0.028 CID_154699581 0.115 0.021 CID_154699503 | ||
| 0.234 | 0.115 | 0.269 | Hypoxia-inducible factor 1 alpha inhibitor | 0.185 0.171 CID_21806134 0.269 0.084 CID_19432906 | CID_19432906 | |
| 0.158 | 0.04 | 0.158 | Cathepsin H inhibitor | 0.107 0.095 CID_21806134 0.125 0.069 CID_19432906 0.107 0.094 CID_154699503 | ||
| 0.144 | 0.027 | 0.171 | Sphingomyelinase inhibitor | 0.137 0.031 CID_21806134 0.152 0.023 CID_19432906 0.158 0.021 CID_154699581 0.171 0.017 CID_154699503 | CID_154699503 | |
| 0.149 | 0.034 | 0.177 | GABA C receptor agonist | 0.177 0.025 CID_21806134 0.131 0.043 CID_19432906 | CID_21806134 | |
| 0.135 | 0.021 | 0.135 | Glutamate (mGluR) antagonist | |||
| 0.156 | 0.042 | 0.161 | Cholesterol synthesis inhibitor | 0.161 0.04 CID_21806134 0.146 0.047 CID_19432906 0.14 0.05 CID_154699581 0.122 0.063 CID_154699503 | CID_21806134 | |
| 0.145 | 0.034 | 0.145 | TRPA1 agonist | 0.098 0.092 CID_19432906 | ||
| 0.212 | 0.102 | 0.212 | Calpain inhibitor | |||
| 0.166 | 0.057 | 0.166 | Thiol protease inhibitor | 0.158 0.062 CID_21806134 | ||
| 0.158 | 0.05 | 0.166 | Adenylate cyclase stimulant | 0.157 0.052 CID_21806134 0.166 0.039 CID_19432906 0.129 0.104 CID_154699581 0.136 0.088 CID_154699503 | CID_19432906 | |
| 0.115 | 0.007 | 0.115 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.09 0.022 CID_21806134 0.098 0.015 CID_19432906 0.074 0.05 CID_154699581 0.077 0.043 CID_154699503 | ||
| 0.145 | 0.039 | 0.145 | GABA receptor agonist | 0.094 0.085 CID_21806134 | ||
| 0.116 | 0.011 | 0.116 | Phosphodiesterase 1B inhibitor | 0.058 0.044 CID_21806134 | ||
| 0.125 | 0.021 | 0.125 | Phosphodiesterase 3A inhibitor | |||
| 0.117 | 0.013 | 0.117 | Phosphodiesterase VI inhibitor | 0.096 0.022 CID_21806134 0.077 0.047 CID_19432906 | ||
| 0.112 | 0.008 | 0.112 | Phosphodiesterase 1A inhibitor | 0.06 0.04 CID_21806134 | ||
| 0.156 | 0.052 | 0.232 | Alpha-N-acetylglucosaminidase inhibitor | 0.232 0.026 CID_21806134 0.2 0.034 CID_19432906 0.11 0.088 CID_154699503 | CID_21806134 | |
| 0.107 | 0.004 | 0.107 | Leukotriene C antagonist | 0.104 0.004 CID_21806134 0.074 0.011 CID_19432906 0.075 0.01 CID_154699581 0.075 0.01 CID_154699503 | ||
| 0.142 | 0.04 | 0.142 | Sphingosine 1-phosphate receptor 4 antagonist | 0.135 0.049 CID_21806134 | ||
| 0.156 | 0.056 | 0.156 | Neuropeptide Y1 antagonist | 0.146 0.072 CID_21806134 | ||
| 0.257 | 0.159 | 0.257 | 15-Lipoxygenase inhibitor | |||
| 0.131 | 0.033 | 0.131 | Acetylcholine release stimulant | 0.119 0.05 CID_21806134 0.107 0.072 CID_19432906 | ||
| 0.119 | 0.021 | 0.119 | Histamine H2 receptor antagonist | 0.115 0.024 CID_21806134 | ||
| 0.188 | 0.092 | 0.188 | Anticonvulsant | |||
| 0.121 | 0.026 | 0.121 | Glutamate receptor agonist | 0.07 0.063 CID_21806134 | ||
| 0.122 | 0.027 | 0.149 | Interleukin 12 antagonist | 0.149 0.013 CID_21806134 | CID_21806134 | |
| 0.103 | 0.01 | 0.132 | Leukotriene B4 antagonist | 0.132 0.006 CID_21806134 0.093 0.012 CID_19432906 0.053 0.039 CID_154699581 0.054 0.036 CID_154699503 | CID_21806134 | |
| 0.131 | 0.037 | 0.148 | Multidrug resistance-associated protein 1 inhibitor | 0.148 0.026 CID_21806134 | CID_21806134 | |
| 0.113 | 0.02 | 0.131 | Interferon agonist | 0.131 0.014 CID_21806134 0.098 0.031 CID_19432906 0.078 0.055 CID_154699581 0.079 0.053 CID_154699503 | CID_21806134 | |
| 0.097 | 0.004 | 0.097 | Benzodiazepine antagonist | 0.049 0.029 CID_21806134 0.061 0.012 CID_19432906 | ||
| 0.102 | 0.009 | 0.102 | Phosphodiesterase 1C inhibitor | 0.067 0.033 CID_21806134 | ||
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR7) antagonist | 0.064 0.055 CID_21806134 0.077 0.031 CID_19432906 0.065 0.052 CID_154699581 0.083 0.024 CID_154699503 | ||
| 0.132 | 0.04 | 0.132 | Activin receptor-like kinase 4 inhibitor | 0.121 0.051 CID_21806134 | ||
| 0.1 | 0.008 | 0.12 | Glucosylceramidase inhibitor | 0.12 0.005 CID_21806134 0.081 0.015 CID_19432906 0.077 0.017 CID_154699581 0.062 0.029 CID_154699503 | CID_21806134 | |
| 0.118 | 0.027 | 0.118 | Phosphodiesterase 6D inhibitor | 0.101 0.05 CID_21806134 0.089 0.078 CID_19432906 | ||
| 0.132 | 0.042 | 0.132 | Alpha 2c adrenoreceptor antagonist | 0.095 0.07 CID_154699581 | ||
| 0.141 | 0.053 | 0.157 | Aldehyde dehydrogenase inhibitor | 0.157 0.043 CID_21806134 0.101 0.097 CID_19432906 | CID_21806134 | |
| 0.09 | 0.003 | 0.09 | Angiotensin II receptor antagonist | 0.05 0.007 CID_21806134 0.055 0.005 CID_19432906 0.046 0.009 CID_154699581 0.04 0.014 CID_154699503 | ||
| 0.109 | 0.022 | 0.206 | Phenylalanine 4-hydroxylase inhibitor | 0.196 0.007 CID_21806134 0.206 0.006 CID_19432906 | CID_19432906 | |
| 0.101 | 0.016 | 0.101 | Glutamate (mGluR1) antagonist | 0.054 0.044 CID_21806134 | ||
| 0.125 | 0.04 | 0.151 | Adenylate kinase inhibitor | 0.122 0.042 CID_21806134 0.151 0.026 CID_19432906 0.093 0.081 CID_154699503 | CID_19432906 | |
| 0.136 | 0.052 | 0.203 | Beta amyloid protein antagonist | 0.158 0.035 CID_154699581 0.203 0.016 CID_154699503 | CID_154699503 | |
| 0.126 | 0.042 | 0.126 | Mediator release inhibitor | 0.124 0.044 CID_21806134 | ||
| 0.108 | 0.024 | 0.108 | Peroxisome proliferator-activated receptor gamma agonist | 0.085 0.037 CID_21806134 | ||
| 0.14 | 0.056 | 0.14 | Sphingosine 1-phosphate receptor 2 antagonist | 0.123 0.089 CID_21806134 0.123 0.089 CID_19432906 | ||
| 0.108 | 0.025 | 0.108 | mTOR complex 2 inhibitor | 0.098 0.036 CID_21806134 0.091 0.045 CID_19432906 0.084 0.058 CID_154699581 0.088 0.051 CID_154699503 | ||
| 0.201 | 0.118 | 0.201 | Cardiotonic | |||
| 0.086 | 0.005 | 0.086 | Immunoglobulin Fc receptor antagonist | 0.074 0.009 CID_21806134 0.059 0.027 CID_19432906 0.053 0.047 CID_154699581 0.056 0.034 CID_154699503 | ||
| 0.095 | 0.014 | 0.107 | Interferon inducer | 0.107 0.01 CID_21806134 0.081 0.023 CID_19432906 | CID_21806134 | |
| 0.085 | 0.006 | 0.085 | Histamine H2 receptor agonist | 0.052 0.02 CID_21806134 0.043 0.03 CID_154699503 | ||
| 0.092 | 0.013 | 0.092 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.084 | 0.004 | 0.084 | Geranyltranstransferase inhibitor | 0.068 0.009 CID_21806134 0.051 0.022 CID_19432906 0.047 0.026 CID_154699581 0.056 0.017 CID_154699503 | ||
| 0.185 | 0.106 | 0.385 | Hypolipemic | 0.225 0.08 CID_21806134 0.385 0.028 CID_19432906 0.318 0.043 CID_154699581 | CID_19432906 | |
| 0.109 | 0.03 | 0.109 | GABA A receptor agonist | |||
| 0.1 | 0.023 | 0.1 | Transforming growth factor beta 3 antagonist | 0.087 0.044 CID_21806134 | ||
| 0.08 | 0.004 | 0.08 | Leukotriene C4 antagonist | 0.078 0.004 CID_21806134 0.05 0.01 CID_19432906 0.051 0.009 CID_154699581 0.051 0.009 CID_154699503 | ||
| 0.102 | 0.026 | 0.102 | Estrogen receptor alpha antagonist | 0.096 0.03 CID_21806134 0.08 0.049 CID_154699581 0.1 0.027 CID_154699503 | ||
| 0.101 | 0.026 | 0.101 | Adenosine A3 receptor antagonist | |||
| 0.094 | 0.019 | 0.094 | Phospholipase D inhibitor | 0.082 0.032 CID_21806134 0.087 0.026 CID_19432906 | ||
| 0.187 | 0.112 | 0.207 | Nitric-oxide synthase stimulant | 0.178 0.134 CID_21806134 0.207 0.077 CID_19432906 | CID_19432906 | |
| 0.088 | 0.013 | 0.095 | Toll-Like receptor 8 antagonist | 0.095 0.011 CID_21806134 | CID_21806134 | |
| 0.127 | 0.053 | 0.153 | Cystathionine beta-synthase inhibitor | 0.153 0.039 CID_21806134 0.125 0.054 CID_19432906 | CID_21806134 | |
| 0.094 | 0.02 | 0.133 | Alcohol oxidase inhibitor | 0.133 0.012 CID_21806134 0.13 0.013 CID_19432906 | CID_21806134 | |
| 0.098 | 0.024 | 0.098 | Glutamate (mGluR) agonist | |||
| 0.077 | 0.003 | 0.077 | Angiotensin AT1 receptor antagonist | 0.059 0.007 CID_21806134 0.061 0.005 CID_19432906 0.057 0.008 CID_154699581 0.054 0.013 CID_154699503 | ||
| 0.077 | 0.005 | 0.077 | Endothelial nitric-oxide synthase inhibitor | 0.029 0.023 CID_21806134 | ||
| 0.112 | 0.039 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.087 0.077 CID_21806134 0.136 0.018 CID_19432906 | CID_19432906 | |
| 0.085 | 0.012 | 0.085 | Histamine agonist | 0.077 0.015 CID_21806134 | ||
| 0.098 | 0.025 | 0.098 | Ca(v)3.1 blocker | |||
| 0.077 | 0.005 | 0.077 | Dihydrofolate reductase inhibitor | 0.067 0.007 CID_21806134 0.041 0.037 CID_154699503 | ||
| 0.134 | 0.063 | 0.155 | Antibacterial (Helicobacter pylori) | 0.155 0.042 CID_21806134 0.113 0.093 CID_19432906 | CID_21806134 | |
| 0.195 | 0.124 | 0.349 | Spasmolytic | 0.187 0.131 CID_21806134 0.349 0.053 CID_19432906 | CID_19432906 | |
| 0.113 | 0.043 | 0.113 | Phosphodiesterase 7B inhibitor | |||
| 0.075 | 0.004 | 0.075 | Histamine H1 receptor agonist | 0.049 0.02 CID_21806134 0.044 0.029 CID_154699581 0.047 0.023 CID_154699503 | ||
| 0.173 | 0.103 | 0.186 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.17 0.107 CID_21806134 0.186 0.086 CID_19432906 | CID_19432906 | |
| 0.083 | 0.014 | 0.114 | Sphingosine kinase inhibitor | 0.114 0.005 CID_21806134 0.055 0.048 CID_19432906 | CID_21806134 | |
| 0.083 | 0.015 | 0.083 | Transcription factor RelA inhibitor | 0.063 0.045 CID_21806134 0.069 0.031 CID_19432906 | ||
| 0.087 | 0.02 | 0.087 | Potassium channel (Tandem pore domain) blocker | 0.069 0.066 CID_19432906 | ||
| 0.157 | 0.09 | 0.211 | ATPase inhibitor | 0.164 0.079 CID_21806134 0.162 0.083 CID_19432906 0.211 0.029 CID_154699581 0.182 0.055 CID_154699503 | CID_154699581 | |
| 0.117 | 0.051 | 0.136 | Electron transport complex I inhibitor | 0.136 0.03 CID_19432906 0.103 0.077 CID_154699581 0.109 0.064 CID_154699503 | CID_19432906 | |
| 0.105 | 0.039 | 0.107 | Histamine H1 receptor antagonist | 0.107 0.037 CID_21806134 | CID_21806134 | |
| 0.081 | 0.016 | 0.081 | Botulinum neurotoxin type A inhibitor | 0.071 0.024 CID_21806134 0.064 0.032 CID_19432906 | ||
| 0.074 | 0.01 | 0.074 | Pregnane X receptor antagonist | 0.059 0.034 CID_21806134 0.064 0.023 CID_19432906 0.053 0.051 CID_154699503 | ||
| 0.072 | 0.008 | 0.093 | Histamine H3 receptor agonist | 0.093 0.006 CID_21806134 0.033 0.016 CID_154699581 0.036 0.015 CID_154699503 | CID_21806134 | |
| 0.111 | 0.047 | 0.111 | Antihistaminic | 0.108 0.049 CID_21806134 | ||
| 0.072 | 0.008 | 0.072 | Glutamate (mGluR group II) antagonist | 0.046 0.018 CID_21806134 0.044 0.021 CID_19432906 | ||
| 0.157 | 0.094 | 0.157 | Phospholipase C inhibitor | 0.15 0.106 CID_21806134 0.144 0.12 CID_19432906 | ||
| 0.149 | 0.087 | 0.149 | Heat shock protein 90 alpha antagonist | 0.129 0.112 CID_154699581 | ||
| 0.2 | 0.138 | 0.2 | Transcription factor STAT inhibitor | |||
| 0.162 | 0.1 | 0.25 | Amyloid beta aggregation inhibitor | 0.25 0.058 CID_21806134 | CID_21806134 | |
| 0.087 | 0.025 | 0.087 | Peroxisome proliferator-activated receptor gamma antagonist | 0.082 0.031 CID_21806134 0.077 0.038 CID_19432906 | ||
| 0.173 | 0.112 | 0.186 | Potassium channel blocker | 0.186 0.102 CID_21806134 0.154 0.131 CID_19432906 | CID_21806134 | |
| 0.123 | 0.062 | 0.123 | Proteasome inhibitor | |||
| 0.116 | 0.055 | 0.13 | Aminopeptidase B inhibitor | 0.13 0.047 CID_21806134 0.105 0.062 CID_19432906 | CID_21806134 | |
| 0.084 | 0.024 | 0.084 | Carbonic anhydrase stimulant | 0.062 0.038 CID_19432906 | ||
| 0.09 | 0.031 | 0.09 | Glutamate (mGluR group I) antagonist | |||
| 0.145 | 0.085 | 0.173 | Interferon gamma antagonist | 0.132 0.106 CID_21806134 0.173 0.055 CID_19432906 0.157 0.07 CID_154699581 0.139 0.094 CID_154699503 | CID_19432906 | |
| 0.141 | 0.082 | 0.158 | Cytidine deaminase inhibitor | 0.158 0.069 CID_21806134 | CID_21806134 | |
| 0.08 | 0.02 | 0.118 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.118 0.011 CID_21806134 0.093 0.016 CID_19432906 | CID_21806134 | |
| 0.132 | 0.074 | 0.246 | Bone formation stimulant | 0.246 0.026 CID_21806134 | CID_21806134 | |
| 0.112 | 0.055 | 0.158 | 5-Lipoxygenase inhibitor | 0.105 0.06 CID_21806134 0.158 0.035 CID_19432906 | CID_19432906 | |
| 0.1 | 0.043 | 0.107 | Glutamate release inhibitor | 0.107 0.034 CID_19432906 0.083 0.081 CID_154699581 | CID_19432906 | |
| 0.119 | 0.063 | 0.135 | Transcription factor STAT6 inhibitor | 0.135 0.037 CID_21806134 | CID_21806134 | |
| 0.06 | 0.004 | 0.074 | Integrin alphaVbeta1 antagonist | 0.074 0.004 CID_21806134 0.019 0.013 CID_154699581 0.021 0.011 CID_154699503 | CID_21806134 | |
| 0.079 | 0.024 | 0.079 | 5 Hydroxytryptamine 5A antagonist | 0.06 0.044 CID_21806134 | ||
| 0.077 | 0.023 | 0.077 | GABA A receptor antagonist | |||
| 0.087 | 0.033 | 0.087 | Benzodiazepine agonist | |||
| 0.085 | 0.031 | 0.107 | Phosphodiesterase III inhibitor | 0.107 0.02 CID_21806134 | CID_21806134 | |
| 0.107 | 0.053 | 0.118 | Anabolic | 0.118 0.041 CID_19432906 | CID_19432906 | |
| 0.088 | 0.035 | 0.088 | Cannabinoid receptor antagonist | |||
| 0.131 | 0.078 | 0.131 | Cytokine production inhibitor | 0.113 0.096 CID_21806134 | ||
| 0.08 | 0.027 | 0.08 | Cannabinoid CB1 receptor antagonist | |||
| 0.057 | 0.005 | 0.057 | Transforming growth factor beta 2 antagonist | 0.041 0.011 CID_21806134 | ||
| 0.075 | 0.022 | 0.075 | Potassium channel (Ca-activated) blocker | |||
| 0.062 | 0.011 | 0.062 | Dopamine D5 agonist | |||
| 0.073 | 0.021 | 0.073 | Protease activated receptor 1 antagonist | |||
| 0.07 | 0.018 | 0.083 | Epithelial sodium channel blocker | 0.083 0.011 CID_21806134 | CID_21806134 | |
| 0.073 | 0.022 | 0.073 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.026 CID_21806134 0.062 0.035 CID_19432906 | ||
| 0.085 | 0.034 | 0.126 | Sphingosine 1-phosphate receptor 4 agonist | 0.126 0.014 CID_21806134 0.082 0.036 CID_19432906 | CID_21806134 | |
| 0.063 | 0.012 | 0.063 | Glutamate (mGluR group II) agonist | |||
| 0.07 | 0.019 | 0.073 | Diacylglycerol O-acyltransferase inhibitor | 0.073 0.017 CID_21806134 | CID_21806134 | |
| 0.099 | 0.048 | 0.099 | Histamine antagonist | 0.096 0.05 CID_21806134 | ||
| 0.109 | 0.059 | 0.122 | DOPA decarboxylase inhibitor | 0.122 0.043 CID_21806134 0.094 0.09 CID_19432906 | CID_21806134 | |
| 0.097 | 0.047 | 0.107 | Ornithine decarboxylase inhibitor | 0.094 0.051 CID_21806134 0.107 0.037 CID_19432906 | CID_19432906 | |
| 0.066 | 0.017 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.024 CID_21806134 0.073 0.013 CID_19432906 | CID_19432906 | |
| 0.17 | 0.121 | 0.186 | Potassium channel (Voltage-sensitive) blocker | 0.186 0.106 CID_21806134 | CID_21806134 | |
| 0.125 | 0.076 | 0.125 | Vanilloid 1 agonist | 0.122 0.082 CID_21806134 | ||
| 0.07 | 0.021 | 0.07 | AMPA receptor antagonist | |||
| 0.056 | 0.007 | 0.056 | Glutamate (mGluR2) antagonist | 0.032 0.018 CID_21806134 0.031 0.019 CID_19432906 | ||
| 0.073 | 0.024 | 0.073 | GABA receptor antagonist | |||
| 0.128 | 0.079 | 0.128 | Toll-Like receptor 9 antagonist | |||
| 0.057 | 0.009 | 0.057 | Angiotensin AT2 receptor antagonist | |||
| 0.063 | 0.015 | 0.086 | Sphingosine 1-phosphate receptor agonist | 0.086 0.008 CID_21806134 | CID_21806134 | |
| 0.076 | 0.029 | 0.085 | Glutamate (mGluR6) antagonist | 0.078 0.027 CID_21806134 0.085 0.019 CID_19432906 0.062 0.06 CID_154699503 | CID_19432906 | |
| 0.06 | 0.013 | 0.077 | Sphingosine 1-phosphate receptor 1 agonist | 0.077 0.006 CID_21806134 | CID_21806134 | |
| 0.164 | 0.116 | 0.193 | HERG channel blocker | 0.193 0.095 CID_21806134 | CID_21806134 | |
| 0.059 | 0.011 | 0.059 | Glutamate (mGluR2) agonist | |||
| 0.053 | 0.006 | 0.053 | Leukotriene B4 receptor 1 antagonist | 0.051 0.007 CID_21806134 0.04 0.011 CID_19432906 | ||
| 0.077 | 0.03 | 0.077 | Cannabinoid CB1 receptor agonist | 0.076 0.031 CID_21806134 | ||
| 0.057 | 0.011 | 0.088 | Sphingosine kinase 1 inhibitor | 0.088 0.005 CID_21806134 | CID_21806134 | |
| 0.063 | 0.016 | 0.063 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.146 | 0.099 | 0.146 | Antipruritic | 0.13 0.123 CID_21806134 | ||
| 0.078 | 0.033 | 0.103 | Protein kinase C beta inhibitor | 0.103 0.012 CID_21806134 0.074 0.04 CID_19432906 | CID_21806134 | |
| 0.089 | 0.043 | 0.093 | Caspase 7 inhibitor | 0.093 0.037 CID_21806134 | CID_21806134 | |
| 0.052 | 0.006 | 0.052 | Benzodiazepine receptor peripheral-type antagonist | 0.039 0.015 CID_19432906 | ||
| 0.136 | 0.091 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 CID_21806134 | CID_21806134 | |
| 0.06 | 0.015 | 0.06 | Glutamate (mGluR1a) antagonist | 0.05 0.02 CID_21806134 0.037 0.033 CID_19432906 | ||
| 0.077 | 0.032 | 0.077 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 CID_21806134 | ||
| 0.113 | 0.069 | 0.151 | Microtubule formation inhibitor | 0.138 0.045 CID_21806134 0.105 0.083 CID_19432906 0.151 0.037 CID_154699581 0.135 0.047 CID_154699503 | CID_154699581 | |
| 0.076 | 0.031 | 0.076 | Exportin-1 inhibitor | 0.073 0.037 CID_19432906 | ||
| 0.11 | 0.066 | 0.11 | Alpha 2b adrenoreceptor antagonist | |||
| 0.082 | 0.038 | 0.092 | GABA B receptor agonist | 0.092 0.023 CID_21806134 0.079 0.044 CID_19432906 | CID_21806134 | |
| 0.191 | 0.147 | 0.191 | Transcription factor STAT3 inhibitor | 0.176 0.17 CID_19432906 | ||
| 0.066 | 0.022 | 0.066 | Transforming growth factor beta 1 antagonist | 0.043 0.042 CID_21806134 | ||
| 0.083 | 0.039 | 0.101 | Aminopeptidase I inhibitor | 0.101 0.027 CID_21806134 0.083 0.04 CID_19432906 | CID_21806134 | |
| 0.072 | 0.029 | 0.076 | Argininosuccinate synthase inhibitor | 0.053 0.044 CID_21806134 0.076 0.027 CID_19432906 | CID_19432906 | |
| 0.067 | 0.024 | 0.074 | Sphingosine kinase 2 inhibitor | 0.074 0.019 CID_21806134 0.06 0.032 CID_19432906 | CID_21806134 | |
| 0.073 | 0.031 | 0.077 | MDM2 inhibitor | 0.077 0.024 CID_21806134 | CID_21806134 | |
| 0.089 | 0.047 | 0.089 | Acetylcholine nicotinic agonist | |||
| 0.061 | 0.019 | 0.061 | Potassium channel (Inward rectifier) activator | |||
| 0.069 | 0.027 | 0.069 | 5 Hydroxytryptamine 5 antagonist | 0.052 0.051 CID_21806134 | ||
| 0.07 | 0.028 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.061 | 0.02 | 0.061 | Oleamide hydrolase inhibitor | 0.047 0.03 CID_19432906 | ||
| 0.093 | 0.052 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.03 CID_21806134 0.104 0.04 CID_19432906 | CID_21806134 | |
| 0.081 | 0.04 | 0.081 | Vanilloid 4 agonist | 0.069 0.067 CID_19432906 | ||
| 0.06 | 0.019 | 0.06 | Histamine H4 receptor antagonist | |||
| 0.122 | 0.082 | 0.122 | Sodium channel (voltage-gated) blocker | 0.114 0.091 CID_21806134 0.113 0.092 CID_19432906 | ||
| 0.053 | 0.013 | 0.053 | Vascular adhesion protein 1 inhibitor | 0.045 0.019 CID_21806134 | ||
| 0.056 | 0.016 | 0.056 | Histone deacetylase 7 inhibitor | |||
| 0.058 | 0.018 | 0.058 | Potassium channel (ATP-sensitive) activator | |||
| 0.047 | 0.007 | 0.047 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.02 CID_21806134 | ||
| 0.054 | 0.014 | 0.054 | Phosphodiesterase 6C inhibitor | |||
| 0.043 | 0.004 | 0.043 | Nicotinic acid receptor 2 antagonist | 0.033 0.009 CID_21806134 0.028 0.017 CID_19432906 | ||
| 0.071 | 0.032 | 0.071 | Adenosine A1 receptor antagonist | 0.05 0.049 CID_21806134 | ||
| 0.07 | 0.032 | 0.085 | Purinergic P2X1 antagonist | 0.06 0.044 CID_21806134 0.085 0.022 CID_19432906 | CID_19432906 | |
| 0.048 | 0.01 | 0.048 | AMPA 3 receptor antagonist | |||
| 0.098 | 0.061 | 0.098 | Electrolyte absorption antagonist | 0.089 0.075 CID_19432906 | ||
| 0.07 | 0.033 | 0.07 | Protease activated receptor antagonist | |||
| 0.067 | 0.03 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.081 | 0.044 | 0.081 | Telomerase inhibitor | |||
| 0.041 | 0.004 | 0.056 | Toll-Like receptor 8 agonist | 0.056 0.003 CID_21806134 0.028 0.005 CID_19432906 | CID_21806134 | |
| 0.076 | 0.039 | 0.076 | Elastase 1 inhibitor | |||
| 0.047 | 0.011 | 0.047 | Vanilloid 3 antagonist | 0.042 0.018 CID_21806134 0.04 0.022 CID_19432906 | ||
| 0.095 | 0.059 | 0.095 | Potassium channel (Voltage-sensitive) activator | |||
| 0.088 | 0.053 | 0.094 | Myeloperoxidase inhibitor | 0.094 0.042 CID_21806134 | CID_21806134 | |
| 0.073 | 0.038 | 0.073 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.085 | 0.051 | 0.102 | Estrogen-related receptor beta agonist | 0.102 0.023 CID_21806134 0.078 0.073 CID_19432906 | CID_21806134 | |
| 0.068 | 0.034 | 0.068 | Alpha 2 adrenoreceptor agonist | |||
| 0.174 | 0.14 | 0.218 | DNA damaging | 0.218 0.102 CID_21806134 0.17 0.146 CID_154699503 | CID_21806134 | |
| 0.129 | 0.095 | 0.151 | Diuretic | 0.151 0.076 CID_21806134 0.126 0.098 CID_19432906 | CID_21806134 | |
| 0.118 | 0.085 | 0.118 | NADPH oxidase inhibitor | |||
| 0.075 | 0.041 | 0.075 | Neuronal nicotinic receptor antagonist | 0.073 0.042 CID_154699581 0.058 0.057 CID_154699503 | ||
| 0.069 | 0.036 | 0.069 | 5 Hydroxytryptamine 3 agonist | 0.061 0.047 CID_21806134 | ||
| 0.094 | 0.061 | 0.108 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.108 0.047 CID_21806134 0.09 0.065 CID_19432906 | CID_21806134 | |
| 0.093 | 0.061 | 0.123 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 CID_21806134 0.123 0.038 CID_19432906 | CID_19432906 | |
| 0.109 | 0.077 | 0.131 | Caspase 3 inhibitor | 0.131 0.046 CID_21806134 | CID_21806134 | |
| 0.091 | 0.059 | 0.141 | Triose-phosphate isomerase inhibitor | 0.141 0.023 CID_21806134 0.114 0.036 CID_19432906 | CID_21806134 | |
| 0.039 | 0.007 | 0.039 | Purinergic P2Y15 antagonist | 0.031 0.015 CID_21806134 0.034 0.011 CID_19432906 0.03 0.017 CID_154699581 0.033 0.013 CID_154699503 | ||
| 0.061 | 0.03 | 0.061 | Acetyl-CoA transferase 2 inhibitor | 0.059 0.034 CID_154699503 | ||
| 0.057 | 0.026 | 0.057 | Alpha 1L adrenoreceptor antagonist | 0.05 0.044 CID_21806134 | ||
| 0.066 | 0.034 | 0.077 | Androgen agonist | 0.077 0.026 CID_19432906 0.058 0.043 CID_154699581 | CID_19432906 | |
| 0.095 | 0.064 | 0.095 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.082 | 0.051 | 0.108 | Cell adhesion molecule inhibitor | 0.108 0.03 CID_21806134 | CID_21806134 | |
| 0.066 | 0.036 | 0.066 | Calcium channel P-type blocker | 0.06 0.059 CID_21806134 | ||
| 0.128 | 0.098 | 0.128 | Acetylcholine M1 receptor antagonist | 0.124 0.103 CID_21806134 | ||
| 0.062 | 0.032 | 0.066 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 CID_21806134 0.066 0.029 CID_19432906 | CID_19432906 | |
| 0.053 | 0.023 | 0.091 | Phosphodiesterase 3B inhibitor | 0.091 0.013 CID_21806134 | CID_21806134 | |
| 0.078 | 0.048 | 0.156 | Catalase inhibitor | 0.104 0.037 CID_21806134 0.156 0.025 CID_19432906 | CID_19432906 | |
| 0.055 | 0.025 | 0.055 | Glutamate (mGluR5) antagonist | |||
| 0.047 | 0.017 | 0.047 | AMPA 4 receptor antagonist | 0.037 0.032 CID_19432906 | ||
| 0.036 | 0.006 | 0.038 | Integrin alphaVbeta3 antagonist | 0.038 0.005 CID_21806134 | CID_21806134 | |
| 0.075 | 0.045 | 0.076 | Glycine receptor agonist | 0.075 0.046 CID_21806134 0.076 0.044 CID_19432906 | CID_19432906 | |
| 0.034 | 0.004 | 0.034 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 CID_19432906 | ||
| 0.046 | 0.017 | 0.046 | Nicotinic acid receptor agonist | 0.044 0.018 CID_21806134 | ||
| 0.058 | 0.029 | 0.058 | 5 Hydroxytryptamine 1B agonist | |||
| 0.108 | 0.079 | 0.128 | Estrogen antagonist | 0.108 0.079 CID_21806134 0.128 0.042 CID_154699503 | CID_154699503 | |
| 0.055 | 0.026 | 0.055 | Glutamate (mGluR group I) agonist | |||
| 0.147 | 0.118 | 0.147 | Pyruvate kinase inhibitor | |||
| 0.085 | 0.057 | 0.089 | Phosphodiesterase IV inhibitor | 0.089 0.054 CID_21806134 | CID_21806134 | |
| 0.143 | 0.114 | 0.143 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.033 | 0.005 | 0.033 | Complement factor 1s inhibitor | |||
| 0.097 | 0.069 | 0.124 | Estrogen receptor beta antagonist | 0.09 0.083 CID_21806134 0.095 0.074 CID_154699581 0.124 0.028 CID_154699503 | CID_154699503 | |
| 0.159 | 0.131 | 0.159 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.081 | 0.053 | 0.081 | Acetylcholine nicotinic antagonist | 0.08 0.055 CID_154699581 | ||
| 0.076 | 0.049 | 0.076 | MAP-kinase-activated kinase 2 inhibitor | 0.066 0.065 CID_21806134 | ||
| 0.053 | 0.025 | 0.053 | Dopamine beta hydroxylase inhibitor | |||
| 0.062 | 0.034 | 0.079 | Beta 1 adrenoreceptor antagonist | 0.079 0.018 CID_21806134 0.065 0.031 CID_19432906 | CID_21806134 | |
| 0.134 | 0.107 | 0.144 | Melanin inhibitor | 0.144 0.09 CID_19432906 | CID_19432906 | |
| 0.062 | 0.035 | 0.062 | Gonadotropin-releasing hormone receptor agonist | 0.061 0.037 CID_21806134 | ||
| 0.046 | 0.02 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 CID_21806134 | ||
| 0.084 | 0.057 | 0.084 | MAP-kinase-activated kinase inhibitor | |||
| 0.101 | 0.075 | 0.166 | Protein kinase C gamma inhibitor | 0.166 0.024 CID_21806134 0.113 0.059 CID_19432906 | CID_21806134 | |
| 0.091 | 0.065 | 0.091 | Breast cancer-resistant protein inhibitor | |||
| 0.045 | 0.019 | 0.045 | Histone deacetylase 9 inhibitor | |||
| 0.05 | 0.025 | 0.055 | NMDA receptor subunit 3B antagonist | 0.055 0.022 CID_21806134 0.043 0.032 CID_19432906 | CID_21806134 | |
| 0.05 | 0.026 | 0.055 | Purinergic P2Y antagonist | 0.055 0.022 CID_21806134 | CID_21806134 | |
| 0.215 | 0.192 | 0.436 | Antiobesity | 0.237 0.169 CID_21806134 0.436 0.053 CID_19432906 | CID_19432906 | |
| 0.058 | 0.035 | 0.063 | Phosphodiesterase II inhibitor | 0.063 0.028 CID_21806134 0.054 0.041 CID_19432906 | CID_21806134 | |
| 0.075 | 0.052 | 0.075 | Acetylcholine M4 receptor antagonist | |||
| 0.043 | 0.02 | 0.043 | Diamine oxidase inhibitor | 0.042 0.021 CID_21806134 0.036 0.029 CID_19432906 | ||
| 0.05 | 0.026 | 0.05 | Glutamate (mGluR5) agonist | |||
| 0.043 | 0.02 | 0.078 | Sphingosine 1-phosphate receptor 3 agonist | 0.078 0.009 CID_21806134 | CID_21806134 | |
| 0.027 | 0.004 | 0.027 | Angiotensin AT1B receptor antagonist | 0.018 0.007 CID_19432906 | ||
| 0.051 | 0.028 | 0.051 | Aldosterone antagonist | |||
| 0.045 | 0.023 | 0.051 | Integrin alpha5beta1 antagonist | 0.051 0.017 CID_21806134 | CID_21806134 | |
| 0.054 | 0.032 | 0.054 | H+/K+-transporting ATPase inhibitor | 0.047 0.042 CID_21806134 | ||
| 0.128 | 0.106 | 0.128 | Cyclin-dependent kinase 8 inhibitor | 0.127 0.108 CID_21806134 | ||
| 0.055 | 0.033 | 0.055 | Cannabinoid CB2 receptor antagonist | |||
| 0.092 | 0.07 | 0.125 | UDP-glucose 4-epimerase inhibitor | 0.125 0.04 CID_21806134 0.101 0.06 CID_19432906 | CID_21806134 | |
| 0.109 | 0.087 | 0.123 | Nav1.3 sodium channel blocker | 0.123 0.07 CID_21806134 0.102 0.095 CID_154699503 | CID_21806134 | |
| 0.209 | 0.187 | 0.526 | Immunosuppressant | 0.289 0.122 CID_21806134 0.526 0.026 CID_154699581 0.473 0.041 CID_154699503 | CID_154699581 | |
| 0.073 | 0.051 | 0.109 | Glutamate decarboxylase inhibitor | 0.099 0.03 CID_21806134 0.109 0.025 CID_19432906 | CID_19432906 | |
| 0.034 | 0.013 | 0.034 | Thiazolidinedione | |||
| 0.049 | 0.028 | 0.051 | Adenylate cyclase 1 inhibitor | 0.051 0.025 CID_21806134 | CID_21806134 | |
| 0.093 | 0.072 | 0.269 | Bronchodilator | 0.162 0.028 CID_21806134 0.269 0.011 CID_19432906 | CID_19432906 | |
| 0.05 | 0.03 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 CID_21806134 | CID_21806134 | |
| 0.071 | 0.052 | 0.071 | Phosphodiesterase VIII inhibitor | |||
| 0.028 | 0.009 | 0.028 | Integrin beta5 antagonist | 0.027 0.01 CID_21806134 | ||
| 0.041 | 0.022 | 0.041 | Retinoid X receptor antagonist | |||
| 0.027 | 0.008 | 0.027 | Angiotensin AT1A receptor antagonist | |||
| 0.043 | 0.025 | 0.043 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.035 | 0.017 | 0.035 | AMPA 1 receptor antagonist | |||
| 0.061 | 0.043 | 0.061 | Adenosine A2a receptor antagonist | |||
| 0.045 | 0.027 | 0.052 | Guanylate cyclase inhibitor | 0.052 0.019 CID_21806134 0.048 0.023 CID_19432906 | CID_21806134 | |
| 0.064 | 0.047 | 0.064 | Aryl hydrocarbon receptor antagonist | 0.058 0.057 CID_21806134 | ||
| 0.04 | 0.023 | 0.04 | DNA gyrase subunit B inhibitor | 0.039 0.024 CID_19432906 | ||
| 0.037 | 0.019 | 0.037 | Retinoid X alpha receptor antagonist | |||
| 0.197 | 0.181 | 0.215 | Antithrombotic | 0.213 0.162 CID_21806134 0.215 0.16 CID_19432906 | CID_19432906 | |
| 0.136 | 0.119 | 0.136 | Tumour necrosis factor antagonist | |||
| 0.028 | 0.012 | 0.028 | Vanilloid 2 agonist | |||
| 0.039 | 0.023 | 0.039 | Delayed rectifier potassium channel blocker | |||
| 0.051 | 0.035 | 0.062 | Beta 2 adrenoreceptor antagonist | 0.062 0.022 CID_21806134 0.05 0.036 CID_19432906 | CID_21806134 | |
| 0.026 | 0.009 | 0.026 | Imidazoline I1 receptor antagonist | |||
| 0.1 | 0.084 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.024 | 0.007 | 0.024 | Alpha 2c adrenoreceptor agonist | 0.019 0.012 CID_154699581 | ||
| 0.074 | 0.058 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.057 | 0.042 | 0.057 | Calcium channel T-type blocker | |||
| 0.055 | 0.04 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.049 CID_21806134 0.053 0.046 CID_19432906 | ||
| 0.088 | 0.073 | 0.088 | MAO A inhibitor | |||
| 0.06 | 0.045 | 0.06 | Dopamine D3 antagonist | |||
| 0.118 | 0.104 | 0.133 | Mannose-6-phosphate isomerase inhibitor | 0.133 0.081 CID_21806134 | CID_21806134 | |
| 0.022 | 0.007 | 0.022 | Nicotinic acid receptor 1 antagonist | |||
| 0.045 | 0.031 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | 0.047 0.028 CID_21806134 | CID_21806134 | |
| 0.04 | 0.026 | 0.04 | MAP3K5 inhibitor | 0.039 0.026 CID_21806134 | ||
| 0.024 | 0.01 | 0.038 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.016 CID_21806134 0.038 0.005 CID_19432906 | CID_19432906 | |
| 0.08 | 0.066 | 0.08 | CC chemokine 5 receptor agonist | |||
| 0.018 | 0.005 | 0.019 | Integrin beta6 antagonist | 0.019 0.004 CID_21806134 0.014 0.011 CID_154699503 | CID_21806134 | |
| 0.053 | 0.039 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.039 CID_21806134 | ||
| 0.107 | 0.094 | 0.11 | Toll-Like receptor 2 antagonist | 0.11 0.09 CID_21806134 | CID_21806134 | |
| 0.08 | 0.066 | 0.08 | Acetylcholine agonist | |||
| 0.088 | 0.075 | 0.088 | Alpha 2d adrenoreceptor antagonist | |||
| 0.029 | 0.015 | 0.029 | Glucosylceramidase stimulant | |||
| 0.066 | 0.053 | 0.066 | Prostaglandin-E synthase inhibitor | |||
| 0.068 | 0.055 | 0.068 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.028 | 0.015 | 0.028 | Thyroid hormone agonist | 0.025 0.02 CID_21806134 | ||
| 0.025 | 0.012 | 0.025 | Bombesin agonist | |||
| 0.053 | 0.04 | 0.067 | Thromboxane synthase inhibitor | 0.067 0.02 CID_21806134 0.05 0.048 CID_19432906 | CID_21806134 | |
| 0.049 | 0.036 | 0.054 | Phosphodiesterase 2A inhibitor | 0.054 0.029 CID_21806134 0.047 0.039 CID_19432906 | CID_21806134 | |
| 0.057 | 0.044 | 0.064 | Biliverdin reductase inhibitor | 0.064 0.036 CID_21806134 0.058 0.042 CID_19432906 | CID_21806134 | |
| 0.021 | 0.009 | 0.021 | Ileal bile acid transport inhibitor | 0.018 0.01 CID_19432906 | ||
| 0.1 | 0.088 | 0.123 | Cell adhesion inhibitor | 0.123 0.063 CID_21806134 | CID_21806134 | |
| 0.06 | 0.048 | 0.06 | Adenosine A2 receptor antagonist | |||
| 0.053 | 0.041 | 0.074 | Carbonic anhydrase VB inhibitor | 0.074 0.025 CID_21806134 | CID_21806134 | |
| 0.046 | 0.035 | 0.046 | Peroxisome proliferator-activated receptor alpha agonist | 0.044 0.037 CID_21806134 | ||
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.15 | 0.139 | 0.15 | Histone acetyltransferase inhibitor | |||
| 0.106 | 0.095 | 0.126 | Cyclooxygenase 3 inhibitor | 0.126 0.071 CID_19432906 | CID_19432906 | |
| 0.181 | 0.171 | 0.181 | Prostaglandin dehydrogenase inhibitor | |||
| 0.035 | 0.024 | 0.035 | Adenosine uptake inhibitor | |||
| 0.021 | 0.01 | 0.021 | Bombesin 3 receptor agonist | |||
| 0.046 | 0.036 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.065 0.015 CID_21806134 0.053 0.025 CID_19432906 | CID_21806134 | |
| 0.061 | 0.052 | 0.061 | Histone deacetylase inhibitor | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.022 | 0.014 | 0.025 | Vitronectin receptor antagonist | 0.025 0.012 CID_21806134 | CID_21806134 | |
| 0.034 | 0.025 | 0.036 | HMG CoA reductase inhibitor | 0.036 0.021 CID_21806134 | CID_21806134 | |
| 0.028 | 0.02 | 0.031 | Liver X receptor beta antagonist | 0.031 0.018 CID_19432906 | CID_19432906 | |
| 0.021 | 0.013 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.041 | 0.033 | 0.041 | GABA B receptor antagonist | 0.04 0.035 CID_21806134 | ||
| 0.081 | 0.074 | 0.081 | Pim-3 kinase inhibitor | |||
| 0.055 | 0.048 | 0.097 | Carbamoyl phosphate synthetase inhibitor | 0.097 0.022 CID_21806134 0.069 0.035 CID_19432906 | CID_21806134 | |
| 0.047 | 0.04 | 0.047 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.09 | 0.083 | 0.09 | Glutamate (mGluR7) agonist | |||
| 0.049 | 0.042 | 0.049 | Carbonic anhydrase II stimulant | |||
| 0.026 | 0.019 | 0.062 | Kynurenine 3 monooxygenase inhibitor | 0.028 0.017 CID_21806134 0.062 0.005 CID_19432906 | CID_19432906 | |
| 0.062 | 0.055 | 0.108 | Phosphofructokinase-1 inhibitor | 0.108 0.029 CID_21806134 0.077 0.043 CID_19432906 | CID_21806134 | |
| 0.05 | 0.043 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.139 | 0.133 | 0.148 | Catenin beta inhibitor | 0.148 0.11 CID_21806134 | CID_21806134 | |
| 0.045 | 0.039 | 0.045 | Cholesterol esterase inhibitor | |||
| 0.024 | 0.018 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 CID_21806134 0.028 0.012 CID_19432906 | CID_19432906 | |
| 0.217 | 0.211 | 0.372 | Antibacterial | 0.346 0.104 CID_19432906 0.365 0.093 CID_154699581 0.372 0.09 CID_154699503 | CID_154699503 | |
| 0.035 | 0.029 | 0.042 | NMDA receptor subunit 3A antagonist | 0.042 0.024 CID_21806134 0.039 0.026 CID_19432906 | CID_21806134 | |
| 0.043 | 0.037 | 0.051 | Thymidylate synthase inhibitor | 0.051 0.026 CID_21806134 | CID_21806134 | |
| 0.076 | 0.07 | 0.076 | Androgen antagonist | |||
| 0.045 | 0.04 | 0.045 | Adenosine A2b receptor antagonist | |||
| 0.032 | 0.026 | 0.032 | Melatonin receptor 1A agonist | |||
| 0.01 | 0.005 | 0.01 | Corticotropin releasing factor antagonist | |||
| 0.019 | 0.014 | 0.019 | Apolipoprotein B inhibitor | |||
| 0.119 | 0.115 | 0.123 | Heat shock protein 90 antagonist | 0.123 0.109 CID_154699581 | CID_154699581 | |
| 0.06 | 0.056 | 0.06 | Phosphodiesterase 4B inhibitor | |||
| 0.018 | 0.013 | 0.018 | Histamine H4 receptor agonist | |||
| 0.029 | 0.024 | 0.039 | Prostaglandin agonist | 0.034 0.018 CID_21806134 0.039 0.014 CID_19432906 | CID_19432906 | |
| 0.095 | 0.091 | 0.095 | Calcium channel (voltage-sensitive) blocker | |||
| 0.031 | 0.027 | 0.031 | Liver X receptor beta agonist | |||
| 0.052 | 0.048 | 0.052 | Fatty acid synthase inhibitor | |||
| 0.028 | 0.025 | 0.039 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.019 CID_21806134 0.039 0.013 CID_19432906 | CID_19432906 | |
| 0.059 | 0.056 | 0.059 | Acetylcholine M5 receptor agonist | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.029 CID_21806134 0.034 0.03 CID_19432906 | ||
| 0.031 | 0.029 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.032 0.027 CID_21806134 | CID_21806134 | |
| 0.025 | 0.023 | 0.026 | Myristoyl transferase inhibitor | 0.026 0.021 CID_21806134 | CID_21806134 | |
| 0.061 | 0.058 | 0.1 | 5 Hydroxytryptamine 1F antagonist | 0.1 0.031 CID_19432906 | CID_19432906 | |
| 0.048 | 0.046 | 0.048 | Acetyl-CoA transferase inhibitor | |||
| 0.134 | 0.132 | 0.231 | Psychostimulant | 0.231 0.066 CID_19432906 | CID_19432906 | |
| 0.032 | 0.03 | 0.032 | Nicotinic acid receptor 2 agonist | 0.032 0.031 CID_21806134 | ||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.038 | 0.037 | 0.038 | Kainate receptor agonist | |||
| 0.127 | 0.125 | 0.132 | MAP kinase kinase 4 inhibitor | 0.132 0.109 CID_21806134 | CID_21806134 | |
| 0.021 | 0.02 | 0.029 | Prostaglandin E2 agonist | 0.024 0.015 CID_21806134 0.029 0.011 CID_19432906 | CID_19432906 | |
| 0.01 | 0.009 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.047 | 0.046 | 0.072 | Thromboxane antagonist | 0.072 0.025 CID_21806134 0.051 0.04 CID_19432906 | CID_21806134 | |
| 0.087 | 0.086 | 0.094 | Monophenol monooxygenase inhibitor | 0.094 0.08 CID_21806134 | CID_21806134 | |
| 0.059 | 0.058 | 0.078 | Beta adrenoreceptor antagonist | 0.078 0.029 CID_21806134 0.064 0.048 CID_19432906 | CID_21806134 | |
| 0.072 | 0.072 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.022 CID_21806134 | CID_21806134 | |
| 0.084 | 0.084 | 0.101 | Carbonic anhydrase III inhibitor | 0.089 0.076 CID_21806134 0.101 0.061 CID_19432906 | CID_19432906 | |
| 0.065 | 0.065 | 0.075 | Na+ K+ transporting ATPase inhibitor | 0.075 0.055 CID_19432906 | CID_19432906 | |
| 0.119 | 0.12 | 0.123 | Hexokinase inhibitor | 0.123 0.114 CID_21806134 | CID_21806134 | |
| 0.04 | 0.041 | 0.042 | Heme oxygenase inhibitor | 0.042 0.032 CID_19432906 | CID_19432906 | |
| 0.03 | 0.032 | 0.051 | Phosphoglycerate kinase inhibitor | 0.051 0.014 CID_21806134 0.031 0.03 CID_19432906 | CID_21806134 | |
| 0.011 | 0.013 | 0.014 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 CID_19432906 | CID_19432906 | |
| 0.029 | 0.032 | 0.033 | Free fatty acid receptor 1 antagonist | 0.033 0.025 CID_21806134 | CID_21806134 | |
| 0.023 | 0.026 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.014 CID_21806134 0.025 0.019 CID_154699581 | CID_21806134 | |
| 0.065 | 0.068 | 0.095 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.095 0.04 CID_21806134 | CID_21806134 | |
| 0.072 | 0.076 | 0.099 | NMDA receptor antagonist | 0.084 0.061 CID_21806134 0.099 0.047 CID_19432906 | CID_19432906 | |
| 0.012 | 0.015 | 0.083 | Calcium-sensing receptor antagonist | 0.083 0.004 CID_19432906 | CID_19432906 | |
| 0.058 | 0.061 | 0.065 | Beta 2 adrenoreceptor agonist | 0.064 0.033 CID_21806134 0.065 0.031 CID_19432906 | CID_19432906 | |
| 0.047 | 0.05 | 0.056 | Alpha-mannosidase inhibitor | 0.056 0.033 CID_21806134 0.051 0.041 CID_19432906 | CID_21806134 | |
| 0.029 | 0.032 | 0.076 | Estrogen-related receptor beta antagonist | 0.076 0.003 CID_21806134 0.03 0.029 CID_19432906 | CID_21806134 | |
| 0.027 | 0.031 | 0.052 | Cholesterol ester transfer protein antagonist | 0.052 0.006 CID_19432906 | CID_19432906 | |
| 0.042 | 0.046 | 0.063 | Potassium channel (Inward rectifier) blocker | 0.063 0.021 CID_19432906 | CID_19432906 | |
| 0.089 | 0.094 | 0.116 | Anesthetic local | 0.116 0.07 CID_19432906 | CID_19432906 | |
| 0.063 | 0.068 | 0.072 | Glutamate dehydrogenase inhibitor | 0.068 0.059 CID_21806134 0.072 0.054 CID_19432906 | CID_19432906 | |
| 0.027 | 0.032 | 0.036 | ATP citrate lysase inhibitor | 0.03 0.024 CID_154699581 0.036 0.017 CID_154699503 | CID_154699503 | |
| 0.011 | 0.017 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.012 CID_21806134 | CID_21806134 | |
| 0.105 | 0.111 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.086 CID_21806134 | CID_21806134 | |
| 0.033 | 0.04 | 0.035 | Glutamate (mGluR8) agonist | 0.035 0.032 CID_21806134 | CID_21806134 | |
| 0.016 | 0.023 | 0.034 | Prostaglandin EP2 agonist | 0.022 0.016 CID_21806134 0.034 0.01 CID_19432906 | CID_19432906 | |
| 0.114 | 0.122 | 0.196 | Insulin secretagoues | 0.196 0.038 CID_21806134 | CID_21806134 | |
| 0.057 | 0.065 | 0.069 | Carbonic anhydrase VA inhibitor | 0.069 0.048 CID_21806134 | CID_21806134 | |
| 0.031 | 0.04 | 0.04 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 CID_19432906 | CID_19432906 | |
| 0.085 | 0.094 | 0.089 | Carbonic anhydrase XV inhibitor | 0.089 0.085 CID_19432906 | CID_19432906 | |
| 0.019 | 0.028 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_21806134 | CID_21806134 | |
| 0.024 | 0.034 | 0.036 | Estrogen-related receptor gamma antagonist | 0.036 0.007 CID_21806134 | CID_21806134 | |
| 0.147 | 0.157 | 0.185 | Immunostimulant | 0.185 0.129 CID_21806134 0.157 0.149 CID_19432906 | CID_21806134 | |
| 0.072 | 0.084 | 0.088 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.088 0.06 CID_21806134 | CID_21806134 | |
| 0.047 | 0.059 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.037 CID_21806134 | CID_21806134 | |
| 0.096 | 0.108 | 0.107 | Interleukin 8 antagonist | 0.107 0.081 CID_21806134 | CID_21806134 | |
| 0.01 | 0.023 | 0.023 | G-protein-coupled receptor 120 agonist | 0.023 0.007 CID_21806134 | CID_21806134 | |
| 0.083 | 0.097 | 0.089 | DNA intercalator | 0.089 0.086 CID_21806134 | CID_21806134 | |
| 0.035 | 0.051 | 0.059 | Thromboxane A2 antagonist | 0.059 0.029 CID_21806134 | CID_21806134 | |
| 0.03 | 0.047 | 0.042 | Membrane dipeptidase inhibitor | 0.042 0.024 CID_19432906 | CID_19432906 | |
| 0.023 | 0.04 | 0.037 | Progesterone antagonist | 0.037 0.024 CID_19432906 | CID_19432906 | |
| 0.053 | 0.071 | 0.066 | NMDA 2 receptor antagonist | 0.066 0.056 CID_19432906 | CID_19432906 | |
| 0.032 | 0.051 | 0.045 | Thymidine kinase inhibitor | 0.045 0.023 CID_21806134 | CID_21806134 | |
| 0.047 | 0.066 | 0.055 | NMDA 2C receptor antagonist | 0.055 0.052 CID_21806134 | CID_21806134 | |
| 0.017 | 0.036 | 0.026 | Cyclin E2 inhibitor | 0.026 0.023 CID_21806134 | CID_21806134 | |
| 0.068 | 0.088 | 0.1 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.1 0.038 CID_21806134 | CID_21806134 | |
| 0.036 | 0.058 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.06 0.031 CID_21806134 | CID_21806134 | |
| 0.033 | 0.056 | 0.044 | Mannosidase inhibitor | 0.044 0.033 CID_21806134 0.041 0.039 CID_19432906 | CID_21806134 | |
| 0.055 | 0.078 | 0.067 | Cathepsin G inhibitor | 0.067 0.057 CID_19432906 | CID_19432906 | |
| 0.018 | 0.042 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 CID_21806134 0.025 0.021 CID_154699581 | CID_21806134 | |
| 0.173 | 0.197 | 0.296 | Immunomodulator | 0.205 0.159 CID_21806134 0.246 0.118 CID_154699581 0.296 0.085 CID_154699503 | CID_154699503 | |
| 0.062 | 0.086 | 0.079 | Keratolytic | 0.079 0.05 CID_21806134 | CID_21806134 | |
| 0.018 | 0.045 | 0.051 | Prostacyclin antagonist | 0.051 0.013 CID_21806134 | CID_21806134 | |
| 0.047 | 0.074 | 0.06 | Carbonic anhydrase V inhibitor | 0.06 0.053 CID_21806134 | CID_21806134 | |
| 0.098 | 0.127 | 0.142 | Protein kinase stimulant | 0.141 0.075 CID_21806134 0.142 0.074 CID_19432906 0.111 0.103 CID_154699503 | CID_19432906 | |
| 0.061 | 0.09 | 0.093 | Adrenaline agonist | 0.081 0.056 CID_21806134 0.093 0.043 CID_19432906 | CID_19432906 | |
| 0.027 | 0.057 | 0.06 | GABA uptake inhibitor | 0.06 0.01 CID_21806134 | CID_21806134 | |
| 0.053 | 0.083 | 0.073 | Beta 3 adrenoreceptor antagonist | 0.06 0.055 CID_21806134 0.073 0.03 CID_19432906 | CID_19432906 | |
| 0.101 | 0.134 | 0.276 | Neurotrophic factor | 0.276 0.009 CID_21806134 | CID_21806134 | |
| 0.013 | 0.046 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.015 CID_21806134 | CID_21806134 | |
| 0.023 | 0.056 | 0.096 | Somatostatin 5 agonist | 0.096 0.005 CID_154699581 | CID_154699581 | |
| 0.079 | 0.112 | 0.103 | AMP-activated protein kinase stimulant | 0.103 0.066 CID_21806134 | CID_21806134 | |
| 0.185 | 0.222 | 0.504 | Toll-Like receptor agonist | 0.249 0.149 CID_21806134 0.504 0.031 CID_19432906 | CID_19432906 | |
| 0.038 | 0.076 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.039 CID_21806134 0.044 0.036 CID_19432906 | CID_19432906 | |
| 0.117 | 0.158 | 0.175 | MAP kinase kinase 2 inhibitor | 0.175 0.1 CID_21806134 | CID_21806134 | |
| 0.112 | 0.155 | 0.133 | Platelet adhesion inhibitor | 0.133 0.127 CID_21806134 | CID_21806134 | |
| 0.054 | 0.099 | 0.086 | Somatostatin 1 agonist | 0.086 0.045 CID_19432906 | CID_19432906 | |
| 0.043 | 0.092 | 0.064 | Prostaglandin F2 alpha antagonist | 0.064 0.039 CID_21806134 | CID_21806134 | |
| 0.151 | 0.202 | 0.201 | DNA synthesis inhibitor | 0.201 0.121 CID_21806134 0.197 0.127 CID_19432906 | CID_21806134 | |
| 0.075 | 0.129 | 0.111 | Alkylator | 0.111 0.077 CID_21806134 | CID_21806134 | |
| 0.065 | 0.122 | 0.101 | Interleukin 5 antagonist | 0.101 0.04 CID_21806134 0.082 0.068 CID_19432906 | CID_21806134 | |
| 0.013 | 0.073 | 0.02 | Follicle-stimulating hormone antagonist | 0.02 0.013 CID_21806134 | CID_21806134 | |
| 0.069 | 0.131 | 0.095 | Adenylate cyclase inhibitor | 0.095 0.089 CID_21806134 | CID_21806134 | |
| 0.037 | 0.1 | 0.061 | Cyclin D1 inhibitor | 0.061 0.041 CID_21806134 | CID_21806134 | |
| 0.006 | 0.07 | 0.042 | Estrogen receptor alpha agonist | 0.042 0.02 CID_154699503 | CID_154699503 | |
| 0.174 | 0.238 | 0.479 | Toll-Like receptor 7 agonist | 0.24 0.156 CID_21806134 0.479 0.036 CID_19432906 | CID_19432906 | |
| 0.082 | 0.157 | 0.114 | Interleukin 4 antagonist | 0.114 0.094 CID_21806134 0.114 0.094 CID_19432906 | CID_19432906 | |
| 0.195 | 0.283 | 0.544 | Cyclophilin D inhibitor | 0.394 0.094 CID_21806134 0.544 0.039 CID_19432906 | CID_19432906 | |
| 0.096 | 0.185 | 0.126 | Hemostatic | 0.126 0.102 CID_21806134 | CID_21806134 | |
| 0.045 | 0.135 | 0.103 | Potassium channel (Ca-activated) activator | 0.103 0.053 CID_21806134 | CID_21806134 | |
| 0.038 | 0.129 | 0.064 | Protein kinase C alpha inhibitor | 0.064 0.053 CID_21806134 | CID_21806134 | |
| 0.11 | 0.203 | 0.188 | Platelet antagonist | 0.188 0.11 CID_21806134 | CID_21806134 | |
| 0.049 | 0.147 | 0.105 | Urease inhibitor | 0.105 0.061 CID_19432906 | CID_19432906 | |
| 0.071 | 0.175 | 0.101 | CDC-like kinase 3 inhibitor | 0.101 0.076 CID_21806134 | CID_21806134 | |
| 0.082 | 0.187 | 0.115 | Cell wall synthesis inhibitor | 0.115 0.107 CID_19432906 | CID_19432906 | |
| 0.016 | 0.123 | 0.044 | HIV-1 protease inhibitor | 0.044 0.029 CID_19432906 | CID_19432906 | |
| 0.063 | 0.173 | 0.128 | Cyclooxygenase 1 inhibitor | 0.128 0.073 CID_19432906 | CID_19432906 | |
| 0.027 | 0.139 | 0.051 | NMDA 2B receptor antagonist | 0.051 0.041 CID_19432906 | CID_19432906 | |
| 0.019 | 0.131 | 0.036 | Retinoic acid alpha receptor agonist | 0.036 0.034 CID_21806134 | CID_21806134 | |
| 0.005 | 0.12 | 0.077 | Estrogen receptor beta agonist | 0.077 0.015 CID_154699503 | CID_154699503 | |
| 0.12 | 0.236 | 0.575 | Hypoglycemic | 0.224 0.093 CID_21806134 0.575 0.01 CID_19432906 | CID_19432906 | |
| 0.053 | 0.171 | 0.109 | Chelator | 0.109 0.066 CID_21806134 | CID_21806134 | |
| 0.087 | 0.216 | 0.143 | Nitric oxide antagonist | 0.143 0.101 CID_154699581 0.135 0.112 CID_154699503 | CID_154699581 | |
| 0.009 | 0.139 | 0.046 | Prostaglandin D2 agonist | 0.046 0.009 CID_19432906 | CID_19432906 | |
| 0.024 | 0.154 | 0.064 | Protein kinase C eta inhibitor | 0.055 0.038 CID_21806134 0.064 0.032 CID_19432906 | CID_19432906 | |
| 0.127 | 0.267 | 0.25 | ErbB-1 antagonist | 0.25 0.051 CID_154699581 0.209 0.08 CID_154699503 | CID_154699581 | |
| 0.005 | 0.154 | 0.128 | Squalene synthetase inhibitor | 0.128 0.005 CID_154699581 | CID_154699581 | |
| 0.049 | 0.223 | 0.091 | MAP kinase kinase 1 inhibitor | 0.091 0.068 CID_21806134 | CID_21806134 | |
| 0.137 | 0.314 | 0.205 | Caspase 3 stimulant | 0.205 0.161 CID_154699581 | CID_154699581 | |
| 0.017 | 0.195 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.062 0.011 CID_19432906 | CID_19432906 | |
| 0.043 | 0.23 | 0.104 | Tubulin antagonist | 0.104 0.097 CID_154699581 | CID_154699581 | |
| 0.014 | 0.21 | 0.044 | Growth hormone release inhibitor | 0.044 0.027 CID_154699581 | CID_154699581 | |
| 0.175 | 0.372 | 0.373 | Antiinflammatory | 0.373 0.156 CID_19432906 | CID_19432906 | |
| 0.048 | 0.259 | 0.089 | Thioredoxin reductase inhibitor | 0.088 0.044 CID_154699581 0.089 0.042 CID_154699503 | CID_154699503 | |
| 0.116 | 0.328 | 0.236 | Peptidyltransferase inhibitor | 0.173 0.141 CID_21806134 0.236 0.061 CID_19432906 | CID_19432906 | |
| 0.031 | 0.262 | 0.246 | Opioid antagonist | 0.246 0.008 CID_154699503 | CID_154699503 | |
| 0.005 | 0.239 | 0.184 | Kinesin antagonist | 0.184 0.004 CID_154699581 | CID_154699581 | |
| 0.005 | 0.239 | 0.184 | Kinesin-like protein 1 inhibitor | 0.184 0.004 CID_154699581 | CID_154699581 | |
| 0.012 | 0.265 | 0.209 | Opioid mu receptor antagonist | 0.209 0.008 CID_154699503 | CID_154699503 | |
| 0.053 | 0.307 | 0.182 | MAP3K9 inhibitor | 0.182 0.025 CID_21806134 | CID_21806134 | |
| 0.01 | 0.277 | 0.266 | Opioid delta receptor antagonist | 0.266 0.005 CID_154699503 | CID_154699503 | |
| 0.008 | 0.274 | 0.094 | Opioid mu receptor agonist | 0.094 0.015 CID_154699503 | CID_154699503 | |
| 0.033 | 0.3 | 0.396 | Opioid kappa receptor antagonist | 0.396 0.004 CID_154699503 | CID_154699503 | |
| 0.039 | 0.329 | 0.095 | Nav1.4 sodium channel blocker | 0.095 0.084 CID_19432906 | CID_19432906 | |
| 0.009 | 0.3 | 0.122 | Antineoplastic antibiotic | 0.122 0.038 CID_154699581 0.078 0.058 CID_154699503 | CID_154699581 | |
| 0.05 | 0.349 | 0.15 | Amyloid beta precursor protein antagonist | 0.15 0.101 CID_21806134 | CID_21806134 | |
| 0.044 | 0.349 | 0.177 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.177 0.077 CID_21806134 | CID_21806134 | |
| 0.095 | 0.405 | 0.25 | Sodium/bile acid cotransporter inhibitor | 0.25 0.128 CID_19432906 | CID_19432906 | |
| 0.013 | 0.324 | 0.062 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 CID_154699581 0.062 0.029 CID_154699503 | CID_154699503 | |
| 0.005 | 0.329 | 0.036 | Potassium channel (Inward rectifier) 1 blocker | 0.036 0.01 CID_19432906 | CID_19432906 | |
| 0.01 | 0.341 | 0.164 | Neuraminidase inhibitor | 0.164 0.005 CID_19432906 | CID_19432906 | |
| 0.013 | 0.365 | 0.153 | Neuraminidase (influenza) inhibitor | 0.153 0.007 CID_19432906 | CID_19432906 | |
| 0.011 | 0.364 | 0.027 | DNA polymerase III inhibitor | 0.027 0.022 CID_21806134 | CID_21806134 | |
| 0.007 | 0.363 | 0.068 | Opioid agonist | 0.068 0.024 CID_154699503 | CID_154699503 | |
| 0.103 | 0.463 | 0.357 | Apoptosis agonist | 0.357 0.135 CID_154699581 0.327 0.154 CID_154699503 | CID_154699581 | |
| 0.006 | 0.366 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.028 CID_19432906 | CID_19432906 | |
| 0.039 | 0.455 | 0.129 | T cell inhibitor | 0.129 0.012 CID_154699581 0.09 0.038 CID_154699503 | CID_154699581 | |
| 0.02 | 0.437 | 0.12 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 CID_154699581 0.12 0.02 CID_154699503 | CID_154699503 | |
| 0.02 | 0.461 | 0.156 | Mcl-1 antagonist | 0.156 0.084 CID_21806134 | CID_21806134 | |
| 0.007 | 0.451 | 0.044 | Microtubule stabilization | 0.044 0.035 CID_154699581 | CID_154699581 | |
| 0.004 | 0.517 | 0.046 | Opioid kappa receptor agonist | 0.046 0.027 CID_154699503 | CID_154699503 | |
| 0.019 | 0.59 | 0.47 | Antimitotic | 0.249 0.06 CID_19432906 0.47 0.015 CID_154699581 | CID_154699581 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |